Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/2e/24/09/2e240939-baaf-cca2-2c7a-0cbca1e01c2a/mza_15011558065103433551.jpeg/600x600bb.jpg
Invest 2025
Yahoo Finance
25 episodes
1 day ago
Where Wall St. meets "what's next?" Join top CEOs, investors and innovators as we decode the trends shaping your money and the future of finance.
Show more...
Investing
Business,
News
RSS
All content for Invest 2025 is the property of Yahoo Finance and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Where Wall St. meets "what's next?" Join top CEOs, investors and innovators as we decode the trends shaping your money and the future of finance.
Show more...
Investing
Business,
News
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/2e/24/09/2e240939-baaf-cca2-2c7a-0cbca1e01c2a/mza_15011558065103433551.jpeg/600x600bb.jpg
Pfizer CEO: AI will help with medicine's next big breakthrough
Invest 2025
15 minutes
3 days ago
Pfizer CEO: AI will help with medicine's next big breakthrough
Fresh off Pfizer's (PFE) $10 billion battle to acquire Metsera (MTSR), Pfizer chairman and CEO Albert Bourla tells Yahoo Finance Executive Editor Brian Sozzi that the future for the pharmaceutical giant is bright. The company plans to enter the GLP-1 space by 2028 and aims to become a leader in the obesity market. Bourla also notes that the next big breakthrough in medicine could be aided by the use of artificial intelligence and discusses Pfizer's relationship with the White House. For full interviews, highlights, and key insights, check out more from Yahoo Finance Invest.
Invest 2025
Where Wall St. meets "what's next?" Join top CEOs, investors and innovators as we decode the trends shaping your money and the future of finance.